Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

A new approach to battling depression?

Posted by Michael Bell on August 24, 2007, at 0:12:54

Neuropsychopharmacology advance online publication 28 March 2007; doi: 10.1038/sj.npp.1301386
Mifepristone Repairs Region-Dependent Alteration of Synapsin I in Hippocampus in Rat Model of Depression

Li-Min Wu1, Hui Han2, Qu-Nan Wang1, Hai-Long Hou1, Hui Tong3, Xue-Bo Yan1 and Jiang-Ning Zhou1

1. 1Hefei National Laboratory for Physical Sciences at Microscale and Department of Neurobiology and Biophysics, School of Life Science, University of Science and Technology of China, Hefei, China
2. 2Department of Neurology, The First Affiliated Hospital of Anhui College of Traditional Chinese Medicine, Hefei, China
3. 3Anhui Geriatric Institute, The First Affiliated Hospital of Anhui Medical University, Hefei, China

Correspondence: Professor J-N Zhou, Department of Neurobiology and Biophysics, School of Life Science, University of Science and Technology of China, Hefei 230027, PR China. Tel: +86 551 3607658; Fax: +86 551 3600408; E-mail: jnzhou@ustc.edu.cn

Received 20 October 2006; Revised 19 January 2007; Accepted 1 February 2007; Published online 28 March 2007.
Top of page
Abstract

Clinical investigations present much evidence that the glucocorticoid receptor (GR) antagonist mifepristone leads to a rapid amelioration of depression. The molecular mechanisms of mifepristone involved in the treatment of depression are not fully understood. Depression is associated with hippocampal plasticity, for which increased excitatory amino acid (EAA) release in CA3 induced by chronic stress is responsible, and glucocorticoids have a permissive role and act synergistically with EAAs in producing neuronal damage. Moreover, glucocorticoids increase synapsin I, which has a key role in the release of neurotransmitter, including EAAs. Hereby, we hypothesize that major depression involves synapsin I alteration and that mifepristone blocks this alteration. In the present study, we observed both the expression of hippocampal synapsin I and depression-associated behavior in a rat model of depression induced by chronic unpredictable mild stress (CUMS). The result showed that a region-dependent synapsin I alteration occurs in the rat hippocampus after 21 days of CUMS, that is, it increases in dentate gyrus (DG)/CA3 and decreases in the CA1 region. Correlation analysis indicated that the decrease of synapsin I in CA1 is highly correlated with the increase in the DG/CA3 subfield. Simultaneously, the region-dependent alteration of synapsin I is correlated with depression-associated behaviors. Both the alteration of synapsin I and the depression-associated behavior were rapidly restored after treatment with mifepristone for 1 week. The result suggests that the molecular mechanism underlying the treatment of depression with mifepristone is associated with the rapid repair of the synaptic alteration.


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:Michael Bell thread:778230
URL: http://www.dr-bob.org/babble/20070815/msgs/778230.html